Skip to content

Clinical trials

Recruiting Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Status: Recruiting Country / region: Taiwan Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20192
20212
20227
20234
20247
202515
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie6
Merck Sharp & Dohme LLC4
Chang Gung Memorial Hospital3
Amgen2
Astellas Pharma Global Development, Inc.2
Eli Lilly and Company2
Hoffmann-La Roche2
Kaohsiung Medical University Chung-Ho Memorial Hospital2
AstraZeneca1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms46
Carcinoma, Non-Small-Cell Lung9
Lung Neoplasms5
Carcinoma, Hepatocellular4
Colorectal Neoplasms4
Neoplasm Metastasis4
Neoplasms by Site4
Brain Neoplasms3
Breast Neoplasms3
Carcinoma3

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.